12-RECT Corporation Announces Start of Phase IIb Eladur – Bupivacaine) Clinical Trial by King PharmaceuticalsDURECT Corporation that its licensee, King Pharmaceuticals has a phase started IIb clinical study Eladur to assess for the treatment of chronic low back pain. Eladur is an investigational transdermal drug patch to bupivacaine for up to 3 days to be delivered by a single application. This phase IIb study is a 12 – week, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of Eladur in patients with chronic low back pain King expects about 260 patients study study.

Loyola Institutional Review Board issues for the Protection of Human Rights and Research approved the clinical trial following extensive public education activities. Since February, Loyola has been conducting a series of community outreach efforts, including meetings with Community Leadership, an open forum with members of the public, placing public notices in local newspapers and distributing flyers in schools, churches, shops and public health centers.PHA AIDS patients and families in dealing with this devastating illness, has networking possibilities, exit solitude of on on rare disease, particularly useful when localizing medical doctors and medical equipment with experience in the treatment of pulmonary hypertension, forming self-help groups for patients to enable network and open contacts with other and there been to a newsletter, Pathlight a sense of community a sense of community. Http://.. Only licensed GP may use the free space onOver the Pulmonary Hypertension Association established in 1987, to the Pulmonary Hypertension Association mission is to self help groups find a cure for pulmonary hypertension and offers hope for pulmonary hypertonia the Community by supporting, education, advocacy and awareness of.

Other articles from category "pregnancy":

Random articles